FibroScan® is a non-invasive technology quantifying, CAP™ for liver steatosis assessment (NAFLD, NASH). SSM by VCTE™ for portal hypertension assessment and LSM by VCTE™ for liver fibrosis assessment.
This unique, accurate and efficient device brings you extra clinical confidence to support your patient management.
FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 3,500+ peer-reviewed publications and 160+ international guidelines. Our liver health solutions, FibroScan® and Scores by Echosens allow a comprehensive management of liver health.